ArticleOrphanet journal of rare diseases2024

Cost-utility analysis for sublingual versus intravenous edaravone in the treatment of amyotrophic lateral sclerosis.

Chang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.